3.4.6 Automated identification (e.g., bar coding).3.4.1 Key elements on the principal display panel.3.3.6 Use of abbreviations, symbols, and dose designations.3.3.3 Proximity and compatibility of information on the principal display panel.3.2 Planning the design of labels and packages.3 Designing Labels and Packages for Safety.2 Considering Users and Their Environments.1.4 Content contributing to guide development.The appendices contain supplementary information to the guide as follows:Īppendix 2: Human Factors Principles and Assessment Methods Relevant to Labelling and PackagingĪll parts of the guide and its sections should be considered together, i.e., no topic is to be considered in isolation. The section for each component presents background information followed by recommendations. Part 3 addresses the specific components applicable to the design of labels and packages from a safety perspective. This is intended to provide a reference point for all other sections of the guide. It emphasizes the need to consider the environment in which health products are selected and used. Part 2 highlights the importance of the user's perspective. It also provides an overview of the process used in developing the guide. Part 1 presents the objective, introduction, and scope. This document should be read in conjunction with the relevant sections of other applicable Health Canada regulations, guidance documents, and policies. It is anticipated that new research on various topics addressed in this guide will become available in the future, and revisions may be warranted to integrate such new information. The guide reflects the information available during its development and is meant to provide initial considerations when preparing the content and design of labels and packages. The utmost care has been taken to ensure the accuracy of information presented in this guide.

G2 red pill